CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Komipharm International Company Limited Company Snapshot
Komipharm International Company Limited operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Komipharm International Company Limited with three other companies in this sector in South Korea: Choong Ang Vaccine Laboratory (2018 sales of 33.15 billion Korean Won [US$28.41 million] of which 100% was Animal Health Product), G-treeBNT Co Ltd (46.36 billion Korean Won [US$39.73 million] of which 61% was Medicine), and Eu Biologics Co Ltd (24.89 billion Korean Won [US$21.33 million] of which 91% was OCV).

Sales Analysis. Komipharm International Company Limited reported sales of 34.99 billion Korean Won (US$29.99 million) for the year ending December of 2018. This represents a decrease of 4.5% versus 2017, when the company's sales were 36.64 billion Korean Won.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Komipharm International Company Limited
  Stock Performance Chart for Komipharm International Company Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (11/8/2019): 14,250
(Figures in Korean Won)
1 Week -0.3%   13 Weeks 14.0%  
4 Weeks 18.3%   52 Weeks -28.9%  
 
Komipharm International Company Limited Key Data:
  Ticker: 041960 Country: Korea (South)
  Exchanges: SEO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2018 Sales 34,994,051,355
(Year Ending Jan 2019).
Employees: 155
  Currency: Korean Won Market Cap: 906,881,294,550
  Fiscal Yr Ends: December Shares Outstanding: 63,640,793
  Share Type: Common Closely Held Shares: 25,229,137
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.